Geng Guoyan, Yin Zihan, Sun Mingsheng, Xu Guixing, Chen Jiao, Liang Fanrong, Zhao Ling
Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Medicine (Baltimore). 2020 Aug 21;99(34):e21876. doi: 10.1097/MD.0000000000021876.
Cancer continues to be a severe global health problem and the leading cause of death worldwide. Chemotherapy as the main treatment has various side effects, of which marrow suppression is the most common one. Acupuncture had shown clinical effects for marrow suppression after chemotherapy in many studies. However, the efficacy and safety of acupuncture therapy for marrow suppression after chemotherapy remains unclear.
This protocol aims to evaluate the efficacy and safety of acupuncture for marrow suppression after chemotherapy according to the existing randomized controlled trials.
The randomized controlled trials on acupuncture therapy for marrow suppression after chemotherapy will be searched in the database of Embase, PubMed and Cochrane Library, Allied and Complementary Medicine Database (AMED), Chinese Biomedical Literature Database (CBM), China Science and Technology Journal Database (VIP), China National Knowledge Infrastructure (CNKI), WanFang Database (WF), and related registration platforms (WHO ICTRP, Clinical Trials, and Chinese Clinical Trial Register [ChiCTR]), Grey Literature Database from inception to 1 August 2020. The primary outcomes will be assessed using white blood cell (WBC) count, platelet count, hemoglobin count and the number of neutrophils (N). Review Manager V.5.3 software will be applied for statistical analyses. We will measure the risk of bias of the included studies with Cochrane Collaboration Risk of Bias Tool. Finally, Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) will be used to grade the overall quality of evidence. And we will use the intra-group correlation coefficient to assess the consistency of reviewers.
This systematic review and meta-analysis will put a high-quality synthesis of the efficacy and safety of acupuncture treatment in marrow suppression after chemotherapy.
The conclusion of this systematic review will provide evidence to assess acupuncture therapy is an efficacy and safe intervention to treat and control marrow suppression after chemotherapy.
PROSPERO CRD42020163336.
癌症仍然是一个严重的全球健康问题,也是全球主要的死亡原因。化疗作为主要治疗方法有多种副作用,其中骨髓抑制最为常见。许多研究表明针灸对化疗后骨髓抑制有临床疗效。然而,针灸治疗化疗后骨髓抑制的疗效和安全性仍不明确。
本方案旨在根据现有的随机对照试验评估针灸治疗化疗后骨髓抑制的疗效和安全性。
在Embase、PubMed和Cochrane图书馆、联合与补充医学数据库(AMED)、中国生物医学文献数据库(CBM)、中国科技期刊数据库(VIP)、中国知网(CNKI)、万方数据库(WF)以及相关注册平台(世界卫生组织国际临床试验注册平台、ClinicalTrials和中国临床试验注册中心[ChiCTR])、灰色文献数据库中检索从建库至2020年8月1日关于针灸治疗化疗后骨髓抑制的随机对照试验。主要结局将通过白细胞(WBC)计数、血小板计数、血红蛋白计数和中性粒细胞(N)数量进行评估。将应用Review Manager V.5.3软件进行统计分析。我们将使用Cochrane协作偏倚风险工具来衡量纳入研究的偏倚风险。最后,将使用推荐分级、评估、制定与评价(GRADE)对证据的整体质量进行分级。并且我们将使用组内相关系数来评估评审者的一致性。
本系统评价和荟萃分析将对针灸治疗化疗后骨髓抑制的疗效和安全性进行高质量的综合分析。
本系统评价的结论将为评估针灸疗法是治疗和控制化疗后骨髓抑制的一种有效且安全的干预措施提供证据。
PROSPERO注册号:PROSPERO CRD42020163336。